Growing community of inventors

Birkerød, Denmark

Ejvind Jensen

Average Co-Inventor Count = 9.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 17

Ejvind JensenLars Bohn Hansen (1 patent)Ejvind JensenSvend Ludvigsen (1 patent)Ejvind JensenMorten Schlein (1 patent)Ejvind JensenLiselotte Bjerre Knudsen (1 patent)Ejvind JensenKristian Tage Hansen (1 patent)Ejvind JensenDorthe Kot Engelund (1 patent)Ejvind JensenClaude Bonde (1 patent)Ejvind JensenTine Elisabeth Gottschalk Bøving (1 patent)Ejvind JensenLars Hansen (0 patent)Ejvind JensenTine Elisabeth Gottschalk Boving (0 patent)Ejvind JensenEjvind Jensen (1 patent)Lars Bohn HansenLars Bohn Hansen (15 patents)Svend LudvigsenSvend Ludvigsen (15 patents)Morten SchleinMorten Schlein (9 patents)Liselotte Bjerre KnudsenLiselotte Bjerre Knudsen (9 patents)Kristian Tage HansenKristian Tage Hansen (9 patents)Dorthe Kot EngelundDorthe Kot Engelund (8 patents)Claude BondeClaude Bonde (4 patents)Tine Elisabeth Gottschalk BøvingTine Elisabeth Gottschalk Bøving (2 patents)Lars HansenLars Hansen (0 patent)Tine Elisabeth Gottschalk BovingTine Elisabeth Gottschalk Boving (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Novo Nordisk A/s (1 from 1,777 patents)


1 patent:

1. 8158583 - Soluble pharmaceutical compositions for parenteral administration comprising a GLP-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimia

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/26/2025
Loading…